2010 - Efficacy of Postoperative Radiotherapy for Patients with 9th Stage N2 Descriptors in Completely Resected Non-Small Cell Lung Cancer: A Real-World Study
Location: Hall C
Presenter: Yongxing Bao, MD – National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, CAMS & PUMC
2:45 PM - 4:15 PM ET
2011 - Should All Medically Inoperable Patients with Early-Stage NSCLC Need SBRT Treatment?
2012 - A Phase 2 Randomized Study of the BER Inhibitor TRC102 in Combination with Standard Pemetrexed-Platinum-Radiation in Stage III Non-Squamous Non-Small Cell Lung Cancer (NCI 10512)
2017 - Dose to the Cardiac Substructures/Great Vessels and Survival in Patients Treated with Definitive Stereotactic Body Radiation Therapy for Lung Tumors - A Pilot Study
2021 - Role of Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer Patients with Baseline Brain Metastases: A Retrospective Analysis Using IPTW-Adjusted Models
2029 - Role of Whole-Heart Cardiac Dose (WH-CD) on OS in Non-Small Cell Lung Cancer (NSCLC) Patients (Pts) Receiving Post-Operative Radiotherapy (PORT)
2030 - Clinical Outcomes of Early-Stage NSCLC Treated with Definitive SBRT by KRAS and EGFR Status and PD-L1 Expression
Location: Hall C
Presenter: Erik Davies, MD – Cleveland Clinic Taussig Cancer Center
2:45 PM - 4:15 PM ET
2031 - Role of Whole-Heart Dose on Overall Survival (OS) in Locally-Advanced Non-Small Cell Lung Cancer (LA-NSCLC) Patients (Pts) Treated with Concurrent Definitive Chemoradiotherapy (CDCRT)
2032 - Role of Cardiac Sub-Structure (CSS) Dose on Overall Survival (OS) in Locally-Advanced Non-Small Cell Lung Cancer (LA-NSCLC) Patients (Pts) Treated with Concurrent Definitive Chemoradiotherapy (CDCRT)
2033 - Development and Implementation of a Diversity, Equity and Inclusion Task Force in a Radiation Oncology Department at an NCI-Designated Comprehensive Cancer Center
2038 - Inducing Abscopal Response by Local Radiotherapy and Granulocyte-Macrophage Colony-Stimulating Factor as Monotherapy in Patients with Pretreated Advanced Thymic Epithelial Tumors: A Retrospective Anal
2041 - A 3D CNN Model Using Deep Learning Based on Chest CT for Predicting Disease-Free Survival of Patients with Early Stage Lung Cancer Receiving Surgery and SBRT
2042 - Benefit of Consolidative Thoracic Radiotherapy Following First-Line Chemoimmunotherapy in Metastatic NSCLC: Based on PD-L1 Expression
Location: Hall C
Presenter: Aiqin Gao, PhD – Shandong Cancer Hospital Affiliated to Shandong First Medical University
2:45 PM - 4:15 PM ET
2043 - Correlation between irAEs and Efficacy of Consolidative PD-(L)1 Inhibitors Following Chemoradiotherapy in Locally Advanced Non-Small Cell Lung Cancer
Location: Hall C
Presenter: Aiqin Gao, PhD – Shandong Cancer Hospital Affiliated to Shandong First Medical University
2:45 PM - 4:15 PM ET
2044 - Immunomodulatory Effects of Lung SBRT in the Primary and Metastatic Setting: Results from the LAPIS Studies
2046 - Association of Private Schooling with Matching at Highly Ranked Radiation Oncology (RO) Residency Programs: An Analysis of the Texas Star Dataset
2047 - Pretreatment Maximum Standard Uptake Value (SUV max) on Positron Emission Tomography (PET) and the Risk of Distant Failure for Patients with Stage I Non-Small Cell Lung Cancer (NSCLC) Receiving Stereo
2048 - Rates of Attrition in Black Patients with Prostate Cancer Enrolled in Randomized Controlled Trials: A Pooled Secondary Analysis of RTOG 9601, 9902, 0126, and 0415
2053 - Integrating CT Images and Radiotherapy Dose Distribution Maps to Predict the Progression-Free Survival in Locally Advanced Non-Small Cell Lung Cancer Patients
2058 - Digital Spatial Profiling of the Tumor Microenvironment in Patients with Advanced Non-Small Cell Lung Cancer Reveals Biomarkers of Response to Anti-PD1 Antibody
2061 - Unplanned Hospitalizations and Lymphopenia after Proton Beam Therapy (PBT) vs. Intensity-Modulated Radiation Therapy (IMRT) in Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC): An Analysis of 74
2062 - Hypofractionation Improving Loco-Regional Control for Sequential Chemoradiotherapy in Non-Small Cell Lung Cancer. A Multicenter Long Term Experience.
2063 - Outcomes of Stereotactic Body Radiotherapy (SBRT) in Patients with Oligometastatic or Oligoprogressive Lung Metastases from Renal Cell Cancer (RCC)
2066 - Circulating miRNA Profiling Distinguishes Radiation-Induced Fibrosis from Locoregional Recurrence in Patients Who Received Radiotherapy for Lung Cancer
2069 - Safety and Efficacy of Lung SBRT Alone or in Combination with Concurrent Systemic Therapies
Location: Hall C
Presenter: Silpa Karipineni, BS – University of Southern California Keck School of Medicine
2:45 PM - 4:15 PM ET
2070 - What Can 5,045 Peripheral Lymphocyte Count Measurements in 255 Patients Tell Us About Temporal Dynamics and Survival in Non-Small Cell Lung Cancer?
2071 - Radiation Oncologists in Canada: A Comprehensive Survey of Gender Identity, Sexual Orientation, Disability, Race, Ethnicity, Religion and Workplace Harassment and Discrimination Experience
Location: Hall C
Presenter: Amanda Khan, MD, PhD – Tom Baker Cancer Centre / University of Calgary
2:45 PM - 4:15 PM ET
2072 - Risk of Clinically Significant Cardiovascular Disease Associated with Postoperative Radiotherapy in Non-Small Cell Lung Cancer Patients Receiving Surgical Resection Followed By Adjuvant Chemotherapy:
2076 - Transportation Insecurity among Patients with Cancer Undergoing Radiation Therapy
Location: Hall C
Presenter: Kaitlyn Lapen, MD – Memorial Sloan Kettering Cancer Center
2:45 PM - 4:15 PM ET
2077 - Deep Learning Based Estimation of Facial Age for Prognostication in Patients with Early-Stage Non-Small Cell Lung Cancer Undergoing Definitive Stereotactic Body Radiotherapy
Location: Hall C
Presenter: Grace Lee, MD – Harvard Radiation Oncology Program
2:45 PM - 4:15 PM ET
2078 - Dysfunction of CD8+ T Cells around Tumor Cells and Occult Lymph Node Metastasis in NSCLC Patients
2079 - Treatment Toxicity and Outcomes Following Definitive Radiotherapy for Patients with Early-Stage Non-Small Cell Lung Cancers and Pre-Existing Interstitial Lung Disease - A Systematic Review
2080 - Irradiated Tumor Cell-Released Microparticles and the Therapeutic Efficacy of PD-1 Inhibitors by Promoting M1-TAMs Polarization in NSCLC Brain Metastases
2082 - Mouse Mesenchymal Stem Cell-Derived Exosomal miR-466f-3p Reverses EMT Process through Inhibiting AKT/GSK3Ăź Pathway via c-MET in Radiation-Induced Lung Injury
Location: Hall C
Presenter: Yi Li, MD – The 920th Hospital of The Joint Logistic Support Forth
2:45 PM - 4:15 PM ET
2083 - Beta-Adrenergic Receptor Blockers and Survival in Patients with Advanced Non-Small Cell Lung Cancer Combined with Hypertension Undergoing Radiotherapy
2084 - Reduced Frequency and Severity of Radiation Esophagitis without Marginal Failure Risk By Contralateral Esophagus Sparing IMRT in Stage III Non-Small Cell Lung Cancer Patients Undergoing Definitive Con
2087 - Negative Predictors for Surgery Following Induction Chemo-Immunotherapy in Patients with Stage IB-III NSCLC between 2017-2021
Location: Hall C
Presenter: Jason Liu, MD – City of Hope South Pasadena
2:45 PM - 4:15 PM ET
2088 - [18F]AlF-NOTA-QHY-04 PET/CT may Predict Short-Term Outcome for Patients with Limited-Stage Small Cell Lung Cancer Treated by Concurrent Chemoradiotherapy
2092 - Helical Tomotherapy Compared to Intensity-Modulated Radiation Therapy in Hippocampal Avoidance Prophylactic Cranial Irradiation in Patients with Limited-Stage Small-Cell Lung Cancer
2094 - Assessing the Safety and Efficacy of a Hypofractionated Regimen in the Treatment of Early-Stage Non-Small Cell Lung Cancer Patients with Central or Ultracentral Tumors
2095 - Impact of Locoregional Recurrence vs. Distant Metastasis on Overall Survival in Patients with Non-Small Cell Lung Cancer after Surgery: A Secondary Analysis of a Randomized Controlled Trial
2097 - Association between Inter-Fraction Tumor Volume Changes and Patient Outcomes from Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer
2099 - The Impact of the Time of Day of Radiotherapy and Systemic Therapy on Disease Control in Locally Advanced Non-Small Cell Lung Cancer Treated with Chemoradiation and Durvalumab
2103 - Examining Barriers to Practice and Career Development among Non-Female GYN Radiation Oncologists and Non-Male GU Radiation Oncologists: A Nationwide Survey
2104 - Language Disparities in Patient Portal Access and Use among Radiation Oncology Patients Across an Integrated Health Enterprise
Location: Hall C
Presenter: Javier Mora, MD – Harvard Radiation Oncology Program
2:45 PM - 4:15 PM ET
2105 - Dosimetric Impact of Online Adaptive Radiotherapy on a Phase II Study of Hypofractionated Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer
2107 - Understanding the Landscape of Radiation Therapy in Alexandria, Egypt: A Comprehensive Study on Physicians, Supporting Staff and Patients Perspectives
Location: Hall C
Presenter: Ahmed Nawwar, MD, MPH – Harvard Medical College/Brigham and Women's Hospital/Dana Farbar Cancer Institute
2:45 PM - 4:15 PM ET
2108 - Evaluating Baseline Socioeconomic Factors and Ability for Self-Care in Patients with Head and Neck Cancer: Secondary Analysis of a Prospective Pilot Trial
2112 - Real-World Practice Patterns of Immunotherapy, Chemotherapy, and Targeted Therapy with Radiation Therapy in Early-Stage Node-Negative Non-Small Cell Lung Cancer
2113 - COPD, Pneumonia and Diabetes: Common Comorbidities Influence Pneumonitis Risk after ChemoRT and Adjuvant Durvalumab in Stage III Non Small Cell Lung Cancer
2115 - Comprehensive Assessment of Pneumonitis, Pseudoprogression and Hyperprogression among Inoperable Stage III NSCLC Patients Treated with Trimodal Therapy
2124 - Randomized Phase II Trial of Hypofractionated IMRT with 2.5 Gy/Fxn vs. Standard-Fractionated IMRT, Concurrent with Carboplatin/paclitaxel and Followed By Consolidation Durvalumab, for Patients with St
2125 - Does the Implementation of Last Generation Radiation Therapy Equipments Impact in the Interval between the First Clinical Visit to the First Treatment Fraction in a Public Health Scenario?
2127 - Assessing Compliance and Diversity in Early Phase Radiation Oncology Clinical Trials in the United States
Location: Hall C
Presenter: Atefeh Rezaei, MD – Case Comprehensive Cancer Center, Case Western Reserve University
2:45 PM - 4:15 PM ET
2128 - Proton Radiotherapy for Primary Lung Cancer in Patients with Interstitial Lung Disease
Location: Hall C
Presenter: Richard Roden – Mayo Clinic Alix School of Medicine
2:45 PM - 4:15 PM ET
2129 - Self-Reported Financial Toxicity among Rural Cancer Patients Treated with Radiotherapy
Location: Hall C
Presenter: Melanie Rose, MD – Dartmouth-Hitchcock Medical Center
2:45 PM - 4:15 PM ET
2130 - Stereotactic Ablative Radiotherapy for Ultra-Central Lung Tumors: Local Control and Toxicity from a Seventeen-Year Single-Institution Experience
2132 - Validation of Spanish-Language Surveys Utilized for the Navigator-Assisted Hypofractionation Program to Aid Hispanic-American Breast Cancer Patients
2133 - Visualizing the Radiation Experience for Rural Cancer Patients
Location: Hall C
Presenter: Seth Seifert, MA – University of Utah School of Medicine
2:45 PM - 4:15 PM ET
2134 - Global Interobserver Variations of Prescription and Plan Evaluation within Heterogeneous Clinical Target Volume (CTV) Delineations among International Experts in Lung Cancer
2136 - NRG LU008: Phase III Prospective Randomized Trial of Primary Lung Tumor Stereotactic Body Radiation Therapy (SBRT) Followed by Concurrent Mediastinal Chemoradiation for Locally-Advanced Non-Small Cell
Location: Hall C
Presenter: Charles Simone, MD, FASTRO – New York Proton Center and Memorial Sloan Kettering Cancer Center
2:45 PM - 4:15 PM ET
2137 - Machine Learning Based Predictive Modeling of Pneumonitis in Patients Receiving Radiotherapy and Immunotherapy
Location: Hall C
Presenter: Deven Singh, BA – Rutgers Robert Wood Johnson Medical School
2:45 PM - 4:15 PM ET
2138 - A Phase II Randomized Clinical Trial (MC1623) of Concurrent Chemotherapy and Standard (60-66 Gy) vs. High (72 Gy) Dose Proton Beam Therapy (PBT) for Patients with Unresectable, Stage II/III Non-Small
2146 - Effects of Target Coverage on Local Recurrence in Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer
Location: Hall C
Presenter: Shuou Sudo, MD – Nagoya Proton Therapy Center
2:45 PM - 4:15 PM ET
2147 - Comparison of Perceptions of Barriers to Advancement for Women in Radiation Oncology between Men and Women Physicians
Location: Hall C
Presenter: Andrew Tam, MD – City of Hope National Medical Center
2:45 PM - 4:15 PM ET
2148 - The Risk and Survival Significance of Immunotherapy and Targeted Therapy in Patients with Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
2152 - Upfront Stereotactic Body Radiotherapy to the Residual Primary Lung Lesions after First-Line Systemic Therapy in Polymetastatic Non-Small Cell Lung Cancer
Location: Hall C
Presenter: Dan Tao, MD – Chongqing University Cancer Hospital
2:45 PM - 4:15 PM ET
2153 - CRUISER: A Phase 2 Trial of Concurrent durvalumab with Chemoradiation Therapy Followed by durvalumab in Chinese Unresectable Stage III Non-Small Cell Lung Cancer Patients
2154 - Noninvasive Radiomic Biomarkers for Predicting Pseudoprogression and Hyperprogression in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors
2155 - CT-Based Radiomics and Genomics Analysis for Survival Prediction in Stage III Unresectable Non-Small Cell Lung Cancer Treated with Definitive Chemoradiotherapy Following with Immunotherapy
2156 - A Meta-Analysis of Daily vs. Nonconsecutive Fractionation Schedules for Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer
Location: Hall C
Presenter: Maximillian Tjauw – University of Oklahoma Health Sciences Center
2:45 PM - 4:15 PM ET
2157 - 4DPET/4DCT Image Features to Predict Long-Term Response after Chemo-Radiotherapy for Locally-Advanced Non-Small Cell Lung Cancer
2159 - Application of Radiomic and Dosiomic Analyses to Predict for Pneumonitis in Patients with Locally Advanced Non-Small Cell Lung Cancer on the NRG Oncology RTOG 0617 Dataset
2162 - Outcomes of Patients with Interstitial Lung Disease and Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiotherapy
Location: Hall C
Presenter: Samantha Vuong, BS – University of Wisconsin School of Medicine and Public Health
2:45 PM - 4:15 PM ET
2163 - CCL20 Remodeling the Immune Microenvironment via the CD6-Alcam Axis Overcomes NSCLC Immunotherapy Resistance
Location: Hall C
Presenter: Weitao Wen, PhD – Shandong Cancer Hospital Affiliated to Shandong First Medical University
2:45 PM - 4:15 PM ET
2164 - Molecular Imaging Research on 18F-FDG PET/CT and Biomarker Analysis Predict the Efficacy of Neoadjuvant Camrelizumab Combined with Chemotherapy for Resectable Stage IIIA-IIIB NSCLC
2166 - Chemoradiotherapy (CRT) Combined with Consolidative Iruplinalkib for ALK/ROS1+ Unresectable Non-Small Cell Lung Cancer (NSCLC): ALK+ Cohort Results from Part 1 of the INNOVATION Study
2181 - The Efficacy and Safety of TQB2450 Combined with Anlotinib as Maintenance Therapy for LS-SCLC after Definitive Concurrent or Sequential Chemoradiotherapy: A Prospective Phase Ib Study
Location: Hall C
Presenter: Xiaoyan Yin, MBBS – Shandong Cancer Hospital Affiliated to Shandong First Medical University
2:45 PM - 4:15 PM ET
2182 - CT-Based Radiomics Model Predicts Occult Lymph Node Metastasis in Patients with Early-Stage Lung Adenocarcinoma: A Multicenter Study
Location: Hall C
Presenter: Xiaoyan Yin, MBBS – Shandong Cancer Hospital Affiliated to Shandong First Medical University
2:45 PM - 4:15 PM ET
2184 - Predicting Micropapillary or Solid Pattern of Early-Stage Lung Adenocarcinoma with CT-Based Radiomics: A Multicenter Study
Location: Hall C
Presenter: Xiaoyan Yin, MBBS – Shandong Cancer Hospital Affiliated to Shandong First Medical University
2:45 PM - 4:15 PM ET
2185 - Development and External Validation of Predictive Models for Atrial Fibrillation Following Radiotherapy in Non-Small Cell Lung Cancer Patients
2190 - Optimized Hippo-Avoidance Prophylactic Cranial Irradiation in Limited-Stage Small Cell Lung Cancer Treated with First-Line Chemoradiotherapy
Location: Hall C
Presenter: Tianyou Zhan, MD – National Cancer Center/National Clinical Research Center for Cancer Cancer Hospital, CAMS & PUMC
2:45 PM - 4:15 PM ET
2191 - Timing of Once-Daily Thoracic Radiotherapy and Clinical Outcomes in Patients with Limited-Stage Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy
Location: Hall C
Presenter: Tianyou Zhan, MD – National Cancer Center/National Clinical Research Center for Cancer Cancer Hospital, CAMS & PUMC
2:45 PM - 4:15 PM ET
2192 - Conditional Survival and Hazard Rates of Patients with LS-SCLC Underwent IMRT in the First-Line Chemoradiotherapy Era: Influence of Prognostics Factors over Time
Location: Hall C
Presenter: Tianyou Zhan, MD – National Cancer Center/National Clinical Research Center for Cancer Cancer Hospital, CAMS & PUMC
2:45 PM - 4:15 PM ET
2193 - Efficacy and Safety of Thoracic Radiotherapy for Extensive-Stage Small-Cell Lung Cancer in the Era of Immunotherapy: A Real-World Study
Location: Hall C
Presenter: Chaonan Zhang, MD – National Cancer Center/National Clinical Research Center for Cance
2:45 PM - 4:15 PM ET
2194 - Early Cardio-Oncology Intervention in Thoracic Radiotherapy: Results of the Cardiac Aggressive Risk Mitigation (CARMA) Pilot Study
2195 - Personalized Tumor Neoantigen Peptide Vaccine Combined with Radiotherapy in the Treatment of Advanced Tumors - Phase II Randomized Group Study
Location: Hall C
Presenter: Yan Zhang, PhD – Shenzhen Hospital of University of Hong Kong
2:45 PM - 4:15 PM ET
2196 - Radiofrequency Radiation Reshapes Tumor Immune Microenvironment in Pulmonary Metastatic Melanoma By Inducing Active Transformation of Tumor-Infiltrating CD8+ T and NK Cells
2197 - Online Adaptive MR-Guided Fractionated Stereotactic Radiotherapy for Brain Metastases in Patients with Non-Small Cell Lung Cancer (GASTO-1075)
Location: Hall C
Presenter: Hui Liu, MD, PhD – Sun Yat-Sen University Cancer Center
2:45 PM - 4:15 PM ET
2198 - Efficacy of Radiotherapy Combined with Atezolizumab or Docetaxel in Patients with Previously Treated Non-Small-Cell Lung Cancer: A PSM-IPTW Cohort Study
2199 - First-Line Tyrosine Kinase Inhibitor with or without Upfront Stereotactic Body Radiotherapy for Residual Primary Lesions in Advanced EGFR-Mutated Non-Small Cell Lung Cancer
2201 - Real-World Patterns of Cranial Radiation Therapy Among Patients with Brain Metastases from Non-Small Cell Lung Cancer in the Era of CNS-Penetrant Tyrosine Kinase Inhibitors
Location: Hall C
Presenter: Lin Zhu, MD, PhD – Harvard Radiation Oncology Program
2:45 PM - 4:15 PM ET
2202 - Disparities in the Efficacy of Different Treatment Modalities for Inoperable Non-Small Cell Lung Cancer in the Immune Era: A Retrospective, Real-World Study
2203 - Distribution of Responsibility across the HDR Brachytherapy Team: Results of a Nationwide Survey
Location: Hall C
Presenter: Jacqueline Zoberi, PhD – Washington University School of Medicine in St. Louis
2:45 PM - 4:15 PM ET
3774 - Curative-Intent Chemoradiotherapy with Adjuvant Durvalumab plus SBRT to Metastatic Sites in Synchronous Oligometastatic NSCLC
Location: Hall C
Presenter: Kyra McComas, MD – Vanderbilt University Medical Center
4:45 PM - 6:00 PM ET
2204 - Observational Study Based on Interfractional Urinary Bladder Filling Variations during Image Guided Radiotherapy in Cervical Cancer Patients Using Cone Beam Computed Tomography
2205 - Investigating the Impact of CBCT Acquisition Speed on Normal Tissue Structure Localization Accuracy in the Presence of Subject Motion Using a Novel CBCT Scanner
Location: Hall C
Presenter: David Adam, PhD, MS – Johns Hopkins University School of Medicine
4:45 PM - 6:00 PM ET
2206 - Feasibility of a Multi-Isocenter Technique for Long Target Volume MR-Guided Radiotherapy
2207 - Re-Evaluating the Necessity of Pre-Processing Magnetic Resonance Images for Deep Learning-Based Organ Segmentation: A Study on Segmentation Challenges Using MR-Linac Images
2214 - Performance Analysis and Knowledge-Based Quality Assurance of Critical Organ Auto-Segmentation for Craniospinal Irradiation in Pediatric Proton Therapy
Location: Hall C
Presenter: Ozgur Ates, PhD – St. Jude Children's Research Hospital
4:45 PM - 6:00 PM ET
2215 - Developing and Validating a Novel In Vivo Film Dosimetry System for Accurate Radiation Measurement
2226 - The Positioning Accuracy of Individualized Open-Face Mask in Patients with Intracranial Tumors Receiving Radiotherapy - A Randomized Controlled Study
2232 - Dose Prescription with Very High Energy Electron (VHEE): The Clinical Dosimetric Approach Applied to Challenging Cases in Conventional and Flash Delivery Scenarios
2246 - Advancing Pancreatic Cancer Treatment with Bragg Peak Proton FLASH Radiotherapy: Escalating Target Dose through Biological Optimization of the FLASH Effect
2247 - Verification of a Simulation Toolkit Step-By-Step Reaction Diffusion Master Equation Model for Long-Term Simulation of Radiolysis in Fricke Dosimetry
2260 - Tailoring Treatment Margins: A Study of PTV Reduction Using X-Ray Based Adaptive Radiotherapy for Stereotactic Partial Breast Irradiation (A-SPBI) Treatments
Location: Hall C
Presenter: David Parsons, PhD – University of Texas Southwestern Medical Center
4:45 PM - 6:00 PM ET
2261 - Assessing Intra-fractional Organ Motion on Prostate Adaptive Radiotherapy
2268 - Qualitative and Quantitative Evaluation of Adaptation Strategies for Maximal Dosimetric Benefit in Patients Receiving CBCT-Guided Online Adaptive Radiotherapy for Lung Cancer
Location: Hall C
Presenter: Jingwei Duan, PhD – The University of Alabama at Birmingham
4:45 PM - 6:00 PM ET
2269 - Optimization of Treatment Plan Parameters Used in Helical Tomotherapy for Small Cell Lung Cancer Patients with Extensive Pleural Metastasis
2274 - Dosimetric Comparison between Intensity Modulated Radiation Therapy and 3-Dimensional Conformal Radiation Therapy in Both Semi-Lateral Decubitus and Supine Positions for Left Breast Cancer Radiation T
2280 - Leveraging MV-KV Imaging Based Quantitative Intrafractional Motion Tracking for Safe Paraspinal SBRT: The Impact of Patient Movement on Radiation Dose
Location: Hall C
Presenter: Qiyong Fan, PhD – Memorial Sloan Kettering Cancer Center
4:45 PM - 6:00 PM ET
2281 - Creation of Novel Inexpensive Low Artifact Brachytherapy Contrast Markers Compatible with CT and MRI
2298 - Pre-Clinical Evaluation of a Ring Gantry-Based Linac with a Dual-Layer Mlc for Total Marrow and Lymphoid Irradiation and Intensity-Modulated Total Body Irradiation for Pediatric Patients
Location: Hall C
Presenter: Chunhui Han, PhD – City of Hope National Medical Center
4:45 PM - 6:00 PM ET
2299 - Clinical Implementation of SCINTIX Biology-Guided Radiotherapy: A Single Institution Experience from Initial Patient Selection to First SCINTIX Delivery
Location: Hall C
Presenter: Chunhui Han, PhD – City of Hope National Medical Center
4:45 PM - 6:00 PM ET
2300 - First Clinical Experience with a Novel Onboard Dual-Layer Imager
Location: Hall C
Presenter: Ross Berbeco, PhD – Brigham and Women's Hospital/Dana-Farber
4:45 PM - 6:00 PM ET
2301 - Deformable Dose Accumulation and Toxicity Analysis in Prostate Cancer Patients Undergoing MR-Guided Adaptive Radiotherapy
2309 - Automatic Skin Flash Optimization in VMAT with Static-Angle Ports: Effect of Flash Margin Size on Breast and Chestwall Plan Quality and Robustness
2311 - Novel SRS Program Using Universal Inflatable Headrest and Automatic Planning: Retrospective Validation of Patient Immobilization Using Mid-SRS CBCT
Location: Hall C
Presenter: Soon Huh, PhD – University of Florida Proton Therapy Institute
4:45 PM - 6:00 PM ET
2312 - Optimal Planning Organs-at-Risk Volume Margins Considering Displacement of Implanted Fiducial Markers and Organ Motions in High-Risk Prostate Radiation Therapy
Location: Hall C
Presenter: Soon Huh, PhD – University of Florida Proton Therapy Institute
4:45 PM - 6:00 PM ET
2313 - Dosimetric Comparison of O-Ring and C-Arm Linac for Volumetric Modulated Arc Therapy with Simultaneous Integrated Boost of Left-Sided Breast Cancer under Deep Inspiration Breath Hold
2314 - Deep Learning-Based Auto Contouring of Mandibular Sub-Volumes Based on the ClinRad System for Spatial Localization of Osteoradionecrosis of the Jaw
2321 - Feasibility of Automated Radiotherapy Treatment Planning to Increase Patient Throughput in Limited Resource Settings
Location: Hall C
Presenter: Yao Hao, PhD – Washington University in St. Louis
4:45 PM - 6:00 PM ET
2322 - Comparison of Automated Treatment Planning Based on External Beam Radiation Therapy with High Dose Rate Brachytherapy for Focal Intraprostatic Boost Radiation Therapy for Localized Prostate Cancer
2331 - Effect of Prolonged Supine Positioning on CBCT Bowel Gas Artifact in Pancreatic Cancer Patients Undergoing CT-Guided Adaptive Stereotactic Body Radiotherapy
2350 - Evaluation and Validation of Open Access Knowledge Based Planning (KBP) Model in India Developed for Treatment of Bilateral Head and Neck Cancer
Location: Hall C
Presenter: Hefei Liu, MD, MS – University of Pennsvania Radiation Oncology
4:45 PM - 6:00 PM ET
2351 - Compromised Target Coverage with Protracted-Fractionation/Moderately Hypofractionated Radiation Treatment Courses for Pancreatic Cancer
Location: Hall C
Presenter: I-Chia Liu, MD – Johns Hopkins Radiation Oncology Kimmel Cancer Center
4:45 PM - 6:00 PM ET
2353 - A First Quantitative Evaluation of Plan Quality Effects from Gantry Rotational Error on Spot-Scanning Arc Therapy (SPArc)
Location: Hall C
Presenter: Peilin Liu, MD, MS – Corewell Health William Beaumont University Hospital
4:45 PM - 6:00 PM ET
2354 - Investigating the Influence of Spot Error on Plan Quality: A Comparative Study of Spot-Scanning Arc Therapy (SPArc) and Intensity-Modulated Proton Therapy (IMPT)
Location: Hall C
Presenter: Peilin Liu, MD, MS – Corewell Health William Beaumont University Hospital
4:45 PM - 6:00 PM ET
2356 - Improving Plan Quality by Reducing Setup Uncertainty Using an Online Adaptive Proton Workflow
Location: Hall C
Presenter: Weiren Liu, MD, MS – Washington University School of Medicine in St. Louis
4:45 PM - 6:00 PM ET
2357 - A Robust Auto-Planning Algorithm Based Artificial Intelligence for Pencil Beam Scanning Proton Therapy
Location: Hall C
Presenter: Yaoying Liu, PhD – School of Physics, Beihang University
4:45 PM - 6:00 PM ET
2358 - Retreatment Review for Abdominal Cancer: Assessing the Impact of Deformable Image Registration and AI Auto-Segmentation on Dose Accumulation
Location: Hall C
Presenter: Yilin Liu, PhD – Memorial Sloan Kettering Cancer Center
4:45 PM - 6:00 PM ET
2359 - The Feasibility of Using Daily Online CT Image Evaluation as an Indication to Trigger Adaptive Radiation Therapy for Esophageal Cancer
Location: Hall C
Presenter: Yimei Liu, MS – Sun Yat-Sen University Cancer Center
4:45 PM - 6:00 PM ET
2360 - Intra- and Inter-Fraction Errors and Deformation during Pancreas SBRT: Analysis and Predictability of Dose Variations for Upper Gastrointestinal Organs
2362 - Optimal Dose Fractionation Scheme of SFRT Based on Thread-Effect of Helical Tomotherapy in Carcinoma of Uterine Cervix
Location: Hall C
Presenter: Huanli Luo, PhD – Chongqing University Cancer Hospital
4:45 PM - 6:00 PM ET
2363 - A Patient-Specific Based Strategy for Predicting Deep Inspiration Breath-Hold CT from Free-Breathing CT in Breast Radiotherapy
Location: Hall C
Presenter: Tie Lv, PhD – School of Physics, Beihang University
4:45 PM - 6:00 PM ET
2364 - Effect of Different Bladder Water Injection Volumes on Target Area Dose and OAR in 129 Cases of Radical Cervical Cancer Treated with Intracavitary Brachytherapy: A Real-World Study
2371 - Development of Volumetric Quantitative Evaluation Software for Assessing Respiratory-Induced Target Motion
Location: Hall C
Presenter: Hideharu Miura, PhD – Hiroshima High-Precision Radiotherapy Cancer Center
4:45 PM - 6:00 PM ET
2372 - Evaluating Commercial Auto-Segmentation Software Generated Contours on MRI and their Clinical Acceptability for Cranial Stereotactic Radiosurgery
Location: Hall C
Presenter: Hem Moktan, PhD – University of Kansas Medical Center
4:45 PM - 6:00 PM ET
2374 - Innovative Patient CT Scan Extensions for Accurate Organ Dose Estimations Following Proton and Photon Therapy: A Pilot Study
2376 - Investigating the Feasibility of Using Spot-Scanning Proton Arc Therapy to Mitigate the Dosimetric Perturbations in the Presence of Large Metal Implants
Location: Hall C
Presenter: Derek Mumaw, MD – Corewell Health William Beaumont University Hospital
4:45 PM - 6:00 PM ET
2377 - In Silico Comparison of SPArc and IMPT throughput
Location: Hall C
Presenter: Derek Mumaw, MD – Corewell Health William Beaumont University Hospital
4:45 PM - 6:00 PM ET
2378 - Dosimetric Evaluation of PTV Margin Reduction for Online Adaptive Radiotherapy in Head and Neck Cancer Sequential Boost Treatments
2379 - The Feasibility of Newly Developed AI-Based Automatic Radiotherapy Planning for Lung Cancer in SBRT-VMAT: Comparison with Manual Treatment Planning
Location: Hall C
Presenter: Hikaru Nemoto, MS – University of Yamanashi School of Medicine
4:45 PM - 6:00 PM ET
2380 - Validation of Monte Carlo Calculation on Skin Dose in HDR Brachytherapy for Keloid with PHITS
Location: Hall C
Presenter: Jie Ni, MD – The First Affiliated Hospital of Soochow University
4:45 PM - 6:00 PM ET
2381 - Application of Standardized Tissue Repair Discount Factors to Guide Spinal Cord Dose in Reirradiation
2394 - Reporting Inter-Fraction Patient Positioning Accuracy Using Hyperarc Stereotactic Radiotherapy for Recurrent Head and Neck Cancers with Initial Clinical Outcomes
Location: Hall C
Presenter: Damodar Pokhrel, PhD – UK Kentucky, Markey Comprehensive Cancer Center
4:45 PM - 6:00 PM ET
2395 - Feasibility and Safety of Subsequent Course(s) of Single-Isocenter/Multi-Lesion (SIML) Stereotactic Body Radiation Therapy (SBRT) to Synchronous Primary or Oligometastatic Lung Lesions
Location: Hall C
Presenter: Damodar Pokhrel, PhD – UK Kentucky, Markey Comprehensive Cancer Center
4:45 PM - 6:00 PM ET
2396 - Free-Breathing Gated Proton Pencil Beam Scanning (PBS) Delivery - Proof of Concept Phantom Study with Respiratory Monitory System
2402 - Training a Diffusion-GAN to Improve the Head-and-Neck Intensity Modulated Radiation Therapy Fluence Generator
Location: Hall C
Presenter: Scott Reid, BS – Duke University Medical Center
4:45 PM - 6:00 PM ET
2403 - Initial Validation of Cone Beam Computed Tomography (CBCT) Only Treatment Planning Using a C-Arm Linac CBCT Solution
Location: Hall C
Presenter: Atefeh Rezaei, MD – Case Comprehensive Cancer Center, Case Western Reserve University
4:45 PM - 6:00 PM ET
2405 - Automated Planning Dose Optimization Methods for ProstateSBRT to Generate Synthetic Dose Data for Training a Plan Optimization Deep Learning Neural Network
Location: Hall C
Presenter: Jonathan Sackett, MD – University of Cincinnati - Barrett Cancer Center
4:45 PM - 6:00 PM ET
2406 - From Adults to Pediatrics: The Reliability and Reproducibility of AI Auto-Contouring in Pediatric Cancer Treatment
2410 - Integrating Radiation-Induced Functionally-Weighted Airway Damage Modeling with Radiation-Induced Parenchymal Damage Modeling For Prediction of Post-RT Ventilation Loss
2417 - A Comprehensive Workflow of Selecting Local Tolerance Limits to Detect Systematic Multi-Leaf Collimator Positional Errors by Combining Statistical Process Control and Error Curve Model
Location: Hall C
Presenter: Xin Yi, PhD – The First Affiliated Hospital of Chongqing Medical University
4:45 PM - 6:00 PM ET
2418 - Mobile LIDAR and 3D Sensors as a Feasible Method for the Preparation of 3D Printed Custom Boluses
Location: Hall C
Presenter: Mateusz SpaĹ‚ek, MD, DSc, PhD, MBA – Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie – Panstwowy Instytut Badawczy w Warszawie
4:45 PM - 6:00 PM ET
2419 - Auto-Contouring of Normal Organs Using AI and Intensity-Based Deformable Image Registration Algorithms: Opportunities and Caveats
2425 - A Novel Time-Varying Bi-Parametric Hyperelastic Bio-Mechanical Model for Personalized Lung Tumor Motion and Deformation
Location: Hall C
Presenter: Liang Tan, MS – Chongqing University Cancer Hospital
4:45 PM - 6:00 PM ET
2426 - An Investigation on the Relationships of Target Irregularities, Plan Complexities and Patient-Specific Quality Assurance Pre- and during Treatment
Location: Hall C
Presenter: Xia Tan, MS – Chongqing University Cancer Hospital
4:45 PM - 6:00 PM ET
2427 - Ablative Bone Metastasis Radiotherapy Using Diagnostic Computed Tomography Scans for Planning
2431 - Dosimetric Comparison of Photon and Proton Radiosurgery for Large Arteriovenous Malformations
Location: Hall C
Presenter: Roman Travis, MD – University of Alabama Medical Center
4:45 PM - 6:00 PM ET
2432 - Feasibility and Safety of Multiple Courses of Gamma Knife Radiosurgery Treatment to Recurrent Trigeminal Neuralgia: A Single-Institutional Clinical Outcomes
Location: Hall C
Presenter: James Trosper – University of Kentucky College of Medicine
4:45 PM - 6:00 PM ET
2433 - Driving Efficiency of Lung SAbR X-Ray Based Adaptive Planning with TPS-Integrated Automation Tools
2434 - Accuracy of Patient Setup in Breast Cancer Radiation Therapy Using Cone Beam Computed Tomography and Surface-Guided Radiotherapy - A Comparative Analysis
2439 - Application of Monitoring Internal Tumor Motion with Surface Guided System for Lung Stereotactic Body Radiotherapy in Deep Inspiration Breath-Hold
2450 - Effectiveness of Personalized Open-Face Mask Combined with Styrofoam Fixation in Radiotherapy Treatment of Head and Neck Cancers: A Prospective Randomized Controlled Trial
2456 - Initial Assessment of Organ-at-Risk Variance Using Hounsfield Unit-Accurate Cone Beam CT and Auto-Segmentation for External Beam Radiation Therapy for Prostate Cancer
2457 - Multiplexed Deformable Contour Propagation and Deep Learning Auto Segmentation Using Automatic Contour Quality Assurance for Abdominal MR-Guided Online Adaptive Radiotherapy
2460 - Efficacy of Preheating Bolus for Reducing Setup Errors in Patients with Breast Cancer Undergoing Postoperative Radiotherapy: A Randomized Controlled Study
2465 - Unet-Attention Guided Cycle Generative Adversarial Networks Based Synthetic 4DCT from 4D-CBCT Generation for Lung Cancer Stereotactic Body Radiotherapy
Location: Hall C
Presenter: Xiangyu Zhang – West China Hospital of Sichuan University
4:45 PM - 6:00 PM ET
2466 - Different Treatment Strategies in Microbeam Radiation Therapy (MRT)
Location: Hall C
Presenter: Yating Zhang, MS – Technical University of Munich (TUM), Radiation Oncology
4:45 PM - 6:00 PM ET
2467 - An Intentionally-Overfitting Automatic Contour Quality Assurance Tool for Auto-Segmentation in MR-Guided Online Adaptive Radiotherapy
Location: Hall C
Presenter: Ying Zhang, PhD – University of Texas Southwestern Medical Center at Dallas
4:45 PM - 6:00 PM ET
2468 - Dosimetry and Quality Assurance of a Phase I Trial of Proton GRID Therapy on a Compact Proton Therapy Delivery System
Location: Hall C
Presenter: Xiandong Zhao, PhD – Washington University School of Medicine in St. Louis
4:45 PM - 6:00 PM ET
2469 - Gating QA Measurement to Investigate the Impact of Volumetric Repainting on a Compact Proton Therapy Delivery System
Location: Hall C
Presenter: Xiandong Zhao, PhD – Washington University School of Medicine in St. Louis
4:45 PM - 6:00 PM ET
2470 - Investigating the Portability of an Universal PBS Beam Model in a Compact Proton Therapy Delivery System
Location: Hall C
Presenter: Xiandong Zhao, PhD – Washington University School of Medicine in St. Louis
4:45 PM - 6:00 PM ET
2471 - M6 Intracranial Tumor SBRT Different Fixed Devices Analysis on the Influence of PTV Expansion Boundary